Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.Julien Edeline, Éveline Boucher, Franck Bonnetain et al.|Journal of Clinical Oncology|2017Cited by 110
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studiesJulien Edeline, Tomoki Ebata, Satoshi Hirano et al.|European Journal of Cancer|2022Cited by 38
Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma GroupGilles Achard, Nicolás Isambert, Marie Karanian et al.|European Journal of Surgical Oncology|2023Cited by 6
Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trialJulien Edeline, Éveline Boucher, Franck Bonnetain et al.|Annals of Oncology|2017Cited by 4
55P Adjuvant gemcitabine-based chemotherapy for biliary tract cancer: Pooled analysis of the BCAT and PRODIGE-12 studiesJulien Edeline, Tomoki Ebata, Satoshi Hirano et al.|Annals of Oncology|2020Cited by 1